RICHARD M. BERGENSTAL, MD, is an endocrinologist and the executive director of the International Diabetes Center (IDC) of HealthPartners Institute, as well as an adjunct clinical professor of medicine at the University of Minnesota in Minneapolis, MN. Before joining the IDC in 1983, he was an assistant professor at the University of Chicago in Illinois.

Dr. Bergenstal was a site principal investigator in several landmark National Institutes of Health–funded trials, including the DCCT (Diabetes Control and Complications Trial), ACCORD (Action to Control Cardiovascular Risk in Diabetes), and GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study). These trials demonstrated the necessity of maintaining good glycemic control. Today, Dr. Bergenstal continues to study the most effective tools and teamwork approaches needed to accomplish this goal.

He has worked toward international standardization of continuous glucose monitoring (CGM) metrics such as time in range and of the display of CGM data in the ambulatory glucose profile report. Integrating CGM data in electronic health records and organizing the data to effectively guide diabetes management are his areas of current focus.

Dr. Bergenstal was named the American Diabetes Association’s Outstanding Physician Clinician in 2007 and served as the Association’s President, Medicine & Science, in 2010. He has authored more than 300 peer-reviewed publications and has been included in Best Doctors in America since the listing began in 1992.

Diabetes Spectrum associate editor Anastasia Albanese-O’Neill, PhD, APRN, CDCES, coordinated this From Research to Practice section.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at